SpyGlass Pharma, Inc. (SGP) Institutional Ownership Changes & 13F Activity
SpyGlass Pharma, Inc. (SGP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ra Capital Management, L.P., Nea Management Company, Llc, Sands Capital Alternatives, Llc, Samsara Biocapital, Llc, and Price T Rowe Associates Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Bank Of America Corp | Buy | +28,020 | — | 28,020 | $726.00K | Q1 2026 | May 18, 2026 |
| Ra Capital Management, L.P. | Buy | +8,021,117 | — | 8,021,117 | $207.83M | Q1 2026 | May 15, 2026 |
| Nea Management Company, Llc | Buy | +7,392,301 | — | 7,392,301 | $191.53M | Q1 2026 | May 15, 2026 |
| Samsara Biocapital, Llc | Buy | +2,109,953 | — | 2,109,953 | $54.67M | Q1 2026 | May 15, 2026 |
| Price T Rowe Associates Inc | Buy | +704,440 | — | 704,440 | $18.25M | Q1 2026 | May 15, 2026 |
| Vestal Point Capital, Lp | Buy | +666,760 | — | 666,760 | $17.28M | Q1 2026 | May 15, 2026 |
| Deerfield Management Company, L.P. | Buy | +550,000 | — | 550,000 | $14.25M | Q1 2026 | May 15, 2026 |
| Millennium Management Llc | Buy | +468,794 | — | 468,794 | $12.15M | Q1 2026 | May 15, 2026 |
| First Light Asset Management, Llc | Buy | +375,000 | — | 375,000 | $9.72M | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +126,540 | — | 126,540 | $3.28M | Q1 2026 | May 15, 2026 |
| Charles Schwab Investment Management Inc | Buy | +59,610 | — | 59,610 | $1.54M | Q1 2026 | May 15, 2026 |
| Alyeska Investment Group, L.P. | Buy | +57,000 | — | 57,000 | $1.48M | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Buy | +29,348 | — | 29,348 | $760.41K | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +19,283 | — | 19,283 | $499.62K | Q1 2026 | May 15, 2026 |
| State Street Corp | Buy | +17,250 | — | 17,250 | $446.95K | Q1 2026 | May 15, 2026 |
| Manufacturers Life Insurance Company, The | Buy | +11,870 | — | 11,870 | $307.55K | Q1 2026 | May 15, 2026 |
| Squarepoint Ops Llc | Buy | +7,811 | — | 7,811 | $202.38K | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +4,179 | — | 4,179 | $108.28K | Q1 2026 | May 15, 2026 |
| Barclays Plc | Buy | +140 | — | 140 | $3.63K | Q1 2026 | May 15, 2026 |
| Royal Bank Of Canada | Buy | +85 | — | 85 | $2.00K | Q1 2026 | May 15, 2026 |
| Affinity Asset Advisors, Llc | Buy | +250,000 | — | 250,000 | $6.48M | Q1 2026 | May 14, 2026 |
| Northern Trust Corp | Buy | +20,862 | — | 20,862 | $540.53K | Q1 2026 | May 14, 2026 |
| Franklin Resources Inc | Buy | +300,000 | — | 300,000 | $7.77M | Q1 2026 | May 13, 2026 |
| Blackrock, Inc. | Buy | +144,739 | — | 144,739 | $3.75M | Q1 2026 | May 13, 2026 |
| Monashee Investment Management Llc | Buy | +95,000 | — | 95,000 | $2.46M | Q1 2026 | May 13, 2026 |
| Td Asset Management Inc | Buy | +47,580 | — | 47,580 | $1.23M | Q1 2026 | May 11, 2026 |
| Sands Capital Alternatives, Llc | Buy | +2,500,012 | — | 2,500,012 | $64.78M | Q1 2026 | May 08, 2026 |
| Vanguard Capital Management Llc | Buy | +434,813 | — | 434,813 | $11.27M | Q1 2026 | May 08, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +59,782 | — | 59,782 | $1.55M | Q1 2026 | May 08, 2026 |
| Vanguard Global Advisers, Llc | Buy | +4,927 | — | 4,927 | $127.66K | Q1 2026 | May 08, 2026 |
Frequently asked questions about SGP activity
Which institutional owners are buying SGP?
Institutional owners buying SGP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in SGP activity?
"Buy" means an investor increased their reported position in SGP compared to the prior reporting period. This reflects growing exposure to SpyGlass Pharma, Inc. (SGP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in SGP increasing?
Institutional interest in SGP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related SGP Institutional Insights
- SGP Overview
- SGP 13F Institutional Holders
- SGP Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SGP Insider Trading & SEC Form 4 Activity
- SGP Articles
- Top Institutional Investor Stock Rankings